BD
Stent: A Smarter Approach to Esophageal Stenting
Managing
benign esophageal strictures, especially those resistant to repeated
dilation, remains a clinical challenge. Traditional approaches often require
multiple interventions, increasing both patient burden and healthcare costs.
The
BD Stent, developed by ELLA-CS, introduces a new standard in endoscopic
care—a biodegradable esophageal stent that provides effective treatment
without the need for removal.
What
Is the BD Stent?
The
BD Stent is a self-expanding biodegradable stent designed for
temporary use in the esophagus.
Made
from polydioxanone (PDS), a proven medical polymer, the stent:
·
Maintains structural integrity and radial
force for 6–8 weeks
·
Gradually loses strength over time
·
Fully degrades within 3–4 months
This
eliminates the need for additional procedures to remove the stent, making it an
ideal solution for temporary treatment in benign conditions.
Why
Choose a Biodegradable Esophageal Stent?
Conventional
treatment options for benign strictures often involve:
·
Repeated dilation sessions
·
Placement of removable stents
·
Increased risk of complications and
hospital visits
The
BD Stent offers a more efficient alternative:
·
No removal procedure required
·
Reduced number of interventions
·
Improved patient comfort and compliance
Key
Features and Benefits
No
Need for Removal
The
stent naturally degrades within 3–4 months, avoiding secondary
endoscopic procedures.
Sustained
Radial Force
Provides
consistent dilation for 6–8 weeks, supporting effective healing and
lumen remodeling.
Low
Migration Risk
An
uncovered, dual-flared design helps ensure stable positioning and
minimizes migration.
Strong
Safety Profile
Clinical
data shows:
·
Low migration rate (~6.5%)
·
Minimal major complications (~15%)
·
Mild, manageable discomfort
Accurate
Placement & Imaging Compatibility
·
Gold radiopaque markers for precise positioning
·
MRI Conditional (1.5T & 3T)
Clinical
Indications
The
BD Stent is intended for adult patients (≥18 years) with:
Refractory
benign esophageal strictures,
including:
·
Peptic strictures
·
Caustic strictures
·
Anastomotic strictures
Particularly
in cases where standard dilation therapy has failed.
Implantation
Overview
The
BD Stent is designed for ease of use in endoscopic procedures:
·
Supplied sterile with a delivery system and
compression tool
·
Manually compressed before implantation
·
Deployed under endoscopic and/or
fluoroscopic guidance
·
Recommended use with a 0.035” guidewire
Once
placed, the stent expands, maintains lumen patency, and gradually degrades over
time.
Available
Sizes
The
BD Stent is available in multiple configurations to suit different clinical
needs:
·
Body diameters: 18–25 mm
·
Flare diameters: 23–31 mm
·
Lengths: 60 mm to 135 mm
Custom
sizes, including pediatric options, are also available upon request.
Clinical
Evidence
The
BD Stent is supported by multiple clinical studies, including:
·
Randomized controlled trials comparing
dilation and biodegradable stenting
·
Prospective follow-up studies in refractory
strictures
·
Systematic reviews confirming safety and
efficacy
These
studies demonstrate improved outcomes and reduced need for repeated
interventions.
Advancing
Endoscopy with JAT Medical
At
JAT Medical, we are committed to delivering advanced endoscopic
solutions in collaboration with global innovators like ELLA-CS.
The
BD Stent reflects a shift toward:
·
Minimally invasive treatment
·
Reduced procedural burden
·
Enhanced patient outcomes
Conclusion
The
BD Stent represents a significant advancement in the treatment of benign
esophageal strictures.
By
combining biodegradable technology, sustained therapeutic effect,
and elimination of removal procedures, it offers a smarter, more
efficient approach to patient care.
Contact
Us
To
learn more about the BD Stent or request a demo, contact JAT Medical
today and explore how this innovative solution can support your clinical
practice.